Article
An induced pluripotent stem cell line derived from a patient with neonatal diabetes and Fanconi-Bickel syndrome caused by a homozygous mutation in the SLC2A2 gene.
Stem cell research - 1 Jul 2021
Elsayed Ahmed K, Al-Khawaga Sara, Hussain Khalid, Abdelalim Essam M
Abstract excerpt
Recessive mutations in the glucose transporter gene SLC2A2 (GLUT2) lead to permanent neonatal diabetes (PNDM) and Fanconi Bickel Syndrome (FBS). Here, we generated an induced pluripotent stem cell (iPSC) line, QBRIi012-A, from a 24-month-old boy with FBS and PNDM due to homozygous nonsense mutation in the SLC2A2 gene (c.901C > T). The QBRIi012-A was fully characterized using different approaches. The cell line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
